Peroxisome Proliferator-activated Receptor α (PPARα) Agonist Treatment Reverses PPARα Dysfunction and Abnormalities in Hepatic Lipid Metabolism in Ethanol-fed Mice

Journal of Biological Chemistry - Tập 278 Số 30 - Trang 27997-28004 - 2003
Monika Fischer1, Min You2, Michinaga Matsumoto2, David W. Crabb2
1Department of Medicine, Indiana University School of Medicine and Richard Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana 46202, USA.
2Department of Medicine and Biochemistry and Molecular Biology, Indiana University School of Medicine and Richard Roudebush Veterans Affairs Medical Center, Indianapolis, Indiana 46202

Tóm tắt

Từ khóa


Tài liệu tham khảo

Crabb, 1993, Recent Dev. Alcohol., 11, 207, 10.1007/978-1-4899-1742-3_13

Grunnet, 1986, Alcohol. Clin. Exp. Res., 10, 64S, 10.1111/j.1530-0277.1986.tb05182.x

Bhagwandeen, 1987, J. Pathol., 152, 47, 10.1002/path.1711520107

Yang, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 2557, 10.1073/pnas.94.6.2557

Diehl, 2001, Alcohol. Clin. Exp. Res., 25, 8S, 10.1111/j.1530-0277.2001.tb02368.x

Naveau, 1997, Hepatology, 25, 108, 10.1002/hep.510250120

Bocos, 1995, J. Steroid Biochem. Mol. Biol., 53, 1, 10.1016/0960-0760(95)00093-F

Issemann, 1990, Nature, 347, 645, 10.1038/347645a0

Aoyama, 1998, J. Biol. Chem., 273, 5678, 10.1074/jbc.273.10.5678

Watanabe, 2000, J. Biol. Chem., 275, 22293, 10.1074/jbc.M000248200

Kersten, 1999, J. Clin. Invest., 103, 1489, 10.1172/JCI6223

Leone, 1999, Proc. Natl. Acad. Sci. U. S. A., 96, 7473, 10.1073/pnas.96.13.7473

Hashimoto, 2000, J. Biol. Chem., 275, 28918, 10.1074/jbc.M910350199

Kroetz, 1998, J. Biol. Chem., 273, 31581, 10.1074/jbc.273.47.31581

Ma, 1993, Hepatology, 18, 1247, 10.1002/hep.1840180534

Pignon, 1987, Hepatology, 7, 865, 10.1002/hep.1840070512

Everett, 2000, Liver, 20, 191, 10.1034/j.1600-0676.2000.020003191.x

Panchenko, 1987, Experientia (Basel), 43, 580, 10.1007/BF02143593

Wan, 1995, Life Sci., 56, 307, 10.1016/0024-3205(94)00953-8

Wan, 2000, Hepatol. Res., 19, 117, 10.1016/S1386-6346(00)00089-9

Ma, 1999, Am. J. Med., 106, 70, 10.1016/S0002-9343(98)00361-1

Rabinowitz, 1991, Alcohol, 8, 241, 10.1016/0741-8329(91)90289-9

Tsutsumi, 2001, Alcohol. Clin. Exp. Res., 25, 75S, 10.1111/j.1530-0277.2001.tb02423.x

Spritz, 1966, Proc. Soc. Exp. Biol. Med., 121, 147, 10.3181/00379727-121-30721

Forman, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 4312, 10.1073/pnas.94.9.4312

Galli, 2001, J. Biol. Chem., 276, 68, 10.1074/jbc.M008791200

Lieber, 1989, Hepatology, 10, 501, 10.1002/hep.1840100417

Neish, 1995, J. Biol. Chem., 270, 28903, 10.1074/jbc.270.48.28903

Hildebrandt, 2000, Am. J. Physiol. Endocrinol. Metab., 278, 1078, 10.1152/ajpendo.2000.278.6.E1078

Marsman, 1988, Cancer Res., 48, 6739

You, 2002, J. Biol. Chem., 277, 29342, 10.1074/jbc.M202411200

Roglans, 2001, Biochem. Pharmacol., 62, 803, 10.1016/S0006-2952(01)00701-8

Tai, 2002, Arterioscler. Thromb. Vasc. Biol., 22, 805, 10.1161/01.ATV.0000012302.11991.42

Hardie, 1989, Prog. Lipid Res., 28, 117, 10.1016/0163-7827(89)90010-6

McGarry, 1997, Eur. J. Biochem., 244, 1, 10.1111/j.1432-1033.1997.00001.x

Jauhonen, 1982, Alcohol. Clin. Exp. Res., 6, 350, 10.1111/j.1530-0277.1982.tb04990.x

Motomura, 2001, Am. J. Physiol. Endocrinol. Metab., 281, 420, 10.1152/ajpendo.2001.281.3.E420

Beigneux, 2000, J. Biol. Chem., 275, 16390, 10.1074/jbc.M000953200

Uesugi, 2001, Hepatology, 34, 101, 10.1053/jhep.2001.25350

Jarvelainen, 1999, Hepatology, 29, 1602, 10.1002/hep.510290508

Baraona, 1998, Recent Dev. Alcohol., 14, 97, 10.1007/0-306-47148-5_5

Castelli, 1977, Lancet, 23, 153, 10.1016/S0140-6736(77)90176-3

Marzo, 1970, Klin. Wochenschr., 48, 949, 10.1007/BF01487639

Williams, 1984, Med. Clin. N. Am., 68, 33, 10.1016/S0025-7125(16)31239-1

Munday, 1999, Adv. Enzyme Regul., 39, 205, 10.1016/S0065-2571(98)00016-8

Sapone, 2000, Pharmacogenetics, 10, 321, 10.1097/00008571-200006000-00006

Lacquemant, 2000, Diabetes Metab., 26, 393

Flavell, 2000, Diabetologia, 43, 673, 10.1007/s001250051357